SynthesisProstate cancer and prostatic diseases2026

Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.

Takafumi Yanagisawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.